Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?

<p>Abstract</p> <p>Background</p> <p>The idea that the impact of opioid agonist treatment is influenced by the psychopathological profile of heroin addicts has not yet been investigated, and is based on the concept of a specific therapeutic action displayed by opioid ag...

Full description

Bibliographic Details
Main Authors: Rugani Fabio, Lamanna Francesco, Pacini Matteo, Pani Pier, Rovai Luca, Maremmani Angelo, Schiavi Elisa, Dell'Osso Liliana, Maremmani Icro
Format: Article
Language:English
Published: BMC 2011-05-01
Series:Annals of General Psychiatry
Online Access:http://www.annals-general-psychiatry.com/content/10/1/17
_version_ 1819034563790241792
author Rugani Fabio
Lamanna Francesco
Pacini Matteo
Pani Pier
Rovai Luca
Maremmani Angelo
Schiavi Elisa
Dell'Osso Liliana
Maremmani Icro
author_facet Rugani Fabio
Lamanna Francesco
Pacini Matteo
Pani Pier
Rovai Luca
Maremmani Angelo
Schiavi Elisa
Dell'Osso Liliana
Maremmani Icro
author_sort Rugani Fabio
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The idea that the impact of opioid agonist treatment is influenced by the psychopathological profile of heroin addicts has not yet been investigated, and is based on the concept of a specific therapeutic action displayed by opioid agents on psychopathological symptoms. In the present report we compared the effects of buprenorphine and methadone on the psychopathological symptoms of 213 patients (106 on buprenorphine and 107 on methadone) in a follow-up study lasting 12 months.</p> <p>Methods</p> <p>Drug addiction history was collected by means of the Drug Addiction History Rating Scale (DAH-RS) and psychopathological features were collected by means of the Symptom Checklist-90 (SCL-90), using a special five-factor solution. Toxicological urinalyses were carried out for each patient during the treatment period.</p> <p>Results</p> <p>No statistically significant differences were detected in psychopathological symptoms, including 'worthlessness-being trapped', 'somatization', and 'panic-anxiety'. Methadone proved to be more effective on patients characterized by 'sensitivity-psychoticism', whereas buprenorphine was more effective on patients displaying a 'violence-suicide' symptomatology.</p> <p>Conclusions</p> <p>Heroin-dependent patients with psychiatric comorbidities may benefit from opioid agonist treatment not only because it targets their addictive problem, but also, precisely due to this, because it is effective against their mental disorder too.</p>
first_indexed 2024-12-21T07:35:44Z
format Article
id doaj.art-da5f7c96ff674058a228e971f5323c7d
institution Directory Open Access Journal
issn 1744-859X
language English
last_indexed 2024-12-21T07:35:44Z
publishDate 2011-05-01
publisher BMC
record_format Article
series Annals of General Psychiatry
spelling doaj.art-da5f7c96ff674058a228e971f5323c7d2022-12-21T19:11:27ZengBMCAnnals of General Psychiatry1744-859X2011-05-011011710.1186/1744-859X-10-17Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?Rugani FabioLamanna FrancescoPacini MatteoPani PierRovai LucaMaremmani AngeloSchiavi ElisaDell'Osso LilianaMaremmani Icro<p>Abstract</p> <p>Background</p> <p>The idea that the impact of opioid agonist treatment is influenced by the psychopathological profile of heroin addicts has not yet been investigated, and is based on the concept of a specific therapeutic action displayed by opioid agents on psychopathological symptoms. In the present report we compared the effects of buprenorphine and methadone on the psychopathological symptoms of 213 patients (106 on buprenorphine and 107 on methadone) in a follow-up study lasting 12 months.</p> <p>Methods</p> <p>Drug addiction history was collected by means of the Drug Addiction History Rating Scale (DAH-RS) and psychopathological features were collected by means of the Symptom Checklist-90 (SCL-90), using a special five-factor solution. Toxicological urinalyses were carried out for each patient during the treatment period.</p> <p>Results</p> <p>No statistically significant differences were detected in psychopathological symptoms, including 'worthlessness-being trapped', 'somatization', and 'panic-anxiety'. Methadone proved to be more effective on patients characterized by 'sensitivity-psychoticism', whereas buprenorphine was more effective on patients displaying a 'violence-suicide' symptomatology.</p> <p>Conclusions</p> <p>Heroin-dependent patients with psychiatric comorbidities may benefit from opioid agonist treatment not only because it targets their addictive problem, but also, precisely due to this, because it is effective against their mental disorder too.</p>http://www.annals-general-psychiatry.com/content/10/1/17
spellingShingle Rugani Fabio
Lamanna Francesco
Pacini Matteo
Pani Pier
Rovai Luca
Maremmani Angelo
Schiavi Elisa
Dell'Osso Liliana
Maremmani Icro
Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
Annals of General Psychiatry
title Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
title_full Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
title_fullStr Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
title_full_unstemmed Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
title_short Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
title_sort do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts
url http://www.annals-general-psychiatry.com/content/10/1/17
work_keys_str_mv AT ruganifabio domethadoneandbuprenorphinehavethesameimpactonpsychopathologicalsymptomsofheroinaddicts
AT lamannafrancesco domethadoneandbuprenorphinehavethesameimpactonpsychopathologicalsymptomsofheroinaddicts
AT pacinimatteo domethadoneandbuprenorphinehavethesameimpactonpsychopathologicalsymptomsofheroinaddicts
AT panipier domethadoneandbuprenorphinehavethesameimpactonpsychopathologicalsymptomsofheroinaddicts
AT rovailuca domethadoneandbuprenorphinehavethesameimpactonpsychopathologicalsymptomsofheroinaddicts
AT maremmaniangelo domethadoneandbuprenorphinehavethesameimpactonpsychopathologicalsymptomsofheroinaddicts
AT schiavielisa domethadoneandbuprenorphinehavethesameimpactonpsychopathologicalsymptomsofheroinaddicts
AT dellossoliliana domethadoneandbuprenorphinehavethesameimpactonpsychopathologicalsymptomsofheroinaddicts
AT maremmaniicro domethadoneandbuprenorphinehavethesameimpactonpsychopathologicalsymptomsofheroinaddicts